INDUSTRY SESSION
Session Type
INDUSTRY SESSION
Channel
Madrid
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Session Description
Session not included in the main event CME/CPD credit
EMERGING THERAPIES FOR THE TREATMENT OF T2D
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:00 - 09:00
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Novo Nordisk
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:00 - 09:00
Innovation in therapies for T2D
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:00 - 09:10
Navigating through the treatment options after metformin
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:10 - 09:20
Presenter
Authors
The evolving incretin landscape
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:20 - 09:30
The vulnerable patient: investigating semaglutide in renal impairment and late stage disease
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:30 - 09:40
Presenter
Authors
Cardiovascular outcomes with semaglutide: current and future insights
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:40 - 09:50
Presenter
Authors
Q & A / Panel discussion
Session Name
Session Type
INDUSTRY SESSION
Date
21.02.2020, Friday
Session Time
09:00 - 10:00
Channel
Madrid
Lecture Time
09:50 - 10:00